Fortress Biotech, Inc. (FBIO) stock
FBIONasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as FBIOP
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30
$1.89+0.07 (+3.85%)
Close on Nov 18, 2026Market cap $69.51MP/E –Yield –
Fortress Biotech price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Fortress Biotech's price to sales ratio was 1.0× on Nov 11, 2026, against 1.4× a year earlier. Over the last 5 years it ranged from 0.2× to 3.8×, with a median of 1.1×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.0× | −0.8 |
| 2025 | Dec 31, 2025 | 1.8× | +0.9 |
| 2024 | Dec 31, 2024 | 0.9× | +0.6 |
| 2023 | Dec 29, 2023 | 0.3× | −0.6 |
| 2022 | Dec 30, 2022 | 0.9× | −2.9 |
| 2021 | Dec 31, 2021 | 3.8× | −3.1 |
| 2020 | Dec 31, 2020 | 6.9× | +1.7 |
| 2019 | Dec 31, 2019 | 5.2× | +3.3 |
| 2018 | Dec 31, 2018 | 1.9× | −6.5 |
| 2017 | Dec 29, 2017 | 8.4× | −23.0 |
| 2016 | Dec 30, 2016 | 31.4× | −219.1 |
| 2015 | Dec 31, 2015 | 250.5× | – |
See a number that looks wrong?